CIK 0000721371 · Large accelerated filer
CARDINAL HEALTH INC
Sign in to watch- Ticker
- CAH
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Jun 30
- Incorporated
- OH
- Entity type
- operating
- EIN
- 310958666
- Phone
- 6147573033
- Business address
- 7000 CARDINAL PLACE, DUBLIN, OH, 43017
- Former names
- CARDINAL HEALTH INC, CARDINAL DISTRIBUTION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,552,442
- in 7 filings
Net −$59,552,442. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Hollar Jason M. −$29.4M Chief Executive Officer sold 40% of stake
- Alt Aaron E −$9.9M Chief Financial Officer sold 67% of stake
- Mason Stephen M −$8.3M CEO, GMPD Segment sold 66% of stake
- Mayer Jessica L −$7.0M Chief Legal/Compliance Officer sold 47% of stake
- Greene Michelle D. −$2.7M Chief Information Officer sold 53% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-15 | JOHRI AKHIL Director | Grant or award | +1,965 | 20,071 | ||
| 2023-11-15 | KENNY GREGORY B Director | Grant or award | +3,193 | 59,680 | ||
| 2023-11-15 | Evans David C Director | Grant or award | +1,965 | 12,576 | ||
| 2023-11-15 | Edison Sheri H. Director | Grant or award | +1,965 | 12,051 | ||
| 2023-08-28 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise | +6,712 | $71.43 | $479K | 50,914 |
| 2023-08-28 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Sale | −6,712 | $89.81 | $603K | 44,202 |
| 2023-08-28 | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | Option exercise · Employee Stock Option (right to buy) | −6,712 | 0 | ||
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise | +2,797 | $71.43 | $200K | 22,681 |
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise | +2,496 | $84.27 | $210K | 25,177 |
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise | +2,616 | $83.19 | $218K | 27,793 |
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise | +3,551 | $66.43 | $236K | 31,344 |
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Sale | −20,695 | $86.27 | $1.8M | 10,649 |
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise · Employee Stock Option (right to buy) | −2,797 | 0 | ||
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise · Employee Stock Option (right to buy) | −2,496 | 0 | ||
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise · Employee Stock Option (right to buy) | −2,616 | 0 | ||
| 2023-08-18 | Scherer Mary C. Chief Accounting Officer | Option exercise · Employee Stock Option (right to buy) | −3,551 | 0 | ||
| 2023-08-17 | Mayer Jessica L Chief Legal/Compliance Officer | Sale | −10,668 | $87.68 | $935K | 84,865 |
| 2023-08-17 | Mason Stephen M CEO, Medical Segment | Sale | −10,995 | $86.40 | $950K | 63,860 |
| 2023-08-17 | Mason Stephen M CEO, Medical Segment | Sale | −18,528 | $87.40 | $1.6M | 45,332 |
| 2023-08-17 | Mason Stephen M CEO, Medical Segment | Sale | −7,977 | $88.42 | $705K | 37,355 |
Page 12 of 24 · 478 trades